Should You Buy FibroGen Inc (FGEN) Stock After it Has Gained 8.16% in a Week?

Overall market sentiment has been down on FibroGen Inc (FGEN) stock lately. FGEN receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

FibroGen Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on FGEN!

See Full FGEN Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With FGEN Stock Today?

FibroGen Inc (FGEN) stock is trading at $0.53 as of 12:40 PM on Wednesday, Nov 29, a rise of $0.07, or 14.97% from the previous closing price of $0.46. The stock has traded between $0.45 and $0.59 so far today. Volume today is 2,280,162 compared to average volume of 1,902,176.

More About FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Click Here to get the full Stock Report for FibroGen Inc stock.